Scarica l'app Stockscreener
3.77
0.00%
0.00
Pulmonx Corp Borsa (LUNG) Ultime notizie
Canaccord Genuity Group Lowers Pulmonx (NASDAQ:LUNG) Price Target to $15.00 - Defense World
Pulmonx Corp SEC 10-Q Report - TradingView
Pulmonx Corp (NASDAQ: LUNG) Loss Of -10.08% Compared To 52-Week Low; YTD Fall -44.48% – What Should You Do Now? – Marketing Sentinel - Marketing Sentinel
Pulmonx Corp (LUNG) Stock: A Year of Market Movement, Down and Up - investchronicle.com
In the Green: Pulmonx Corp (LUNG) Closes at 3.77, Up/Down -21.95 from Previous Day - DWinneX
Canaccord cuts Pulmonx stock target to $15, maintains Buy rating By Investing.com - Investing.com Nigeria
Pulmonx (LUNG) Price Target Lowered by Canaccord Genuity | LUNG Stock News - GuruFocus
Leading Lung Disease Treatment Pioneer Pulmonx Takes Stage at Bank of America Healthcare Conference - Stock Titan
Pulmonx (LUNG): Analyst Lowers Price Target, Maintains Overweigh - GuruFocus
Pulmonx (LUNG) Maintains "Buy" Rating with Stable Price Target | - GuruFocus
Canaccord cuts Pulmonx stock target to $15, maintains Buy rating - Investing.com
Pulmonx (LUNG) Receives Target Price Adjustment from Canaccord | - GuruFocus
Pulmonx (LUNG) Target Price Adjusted by Piper Sandler Analyst | - GuruFocus
Pulmonx Corp (LUNG) Q1 2025 Earnings Call Highlights: Strong International Growth Amid Domestic ... - Yahoo
BlackRock, Inc. Reduces Stake in Pulmonx Corp: Analyzing the Imp - GuruFocus
Earnings call transcript: Pulmonx beats EPS forecast despite revenue miss in Q1 2025 - Investing.com Nigeria
Pulmonx Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Pulmonx earnings beat by $0.03, revenue topped estimates - Investing.com
Pulmonx (LUNG) Reaffirms 2025 Revenue and Expense Projections | - GuruFocus
LUNG Reports Strong Q1 Revenue, Surpasses Expectations | LUNG St - GuruFocus
Pulmonx Corp (LUNG) Q1 2025 Earnings: EPS Loss of $0.36 Beats Es - GuruFocus
Pulmonx Co. (NASDAQ:LUNG) Shares Purchased by Renaissance Technologies LLC - Defense World
Geode Capital Management LLC Purchases 9,454 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World
Pulmonx Co. (NASDAQ:LUNG) Shares Sold by Russell Investments Group Ltd. - Defense World
Pulmonx Co. (NASDAQ:LUNG) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Pulmonx stock plunges to 52-week low of $5.38 amid market challenges - Investing.com Nigeria
Vanguard Group Inc. Grows Stock Holdings in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Pulmonx stock plunges to 52-week low, hitting 4.71 USD By Investing.com - Investing.com Canada
Pulmonx stock plunges to 52-week low, hitting 4.71 USD - Investing.com Australia
Leading Lung Treatment Innovator Pulmonx Announces Q1 2025 Earnings Date - Stock Titan
American Century Companies Inc. Grows Stock Position in Pulmonx Co. (NASDAQ:LUNG) - Defense World
151,200 Shares in Pulmonx Co. (NASDAQ:LUNG) Acquired by Norges Bank - Defense World
Pulmonx Corp’s Banking’s 100-Day Moving Average at 6.80: Will the Stock Break Through? - investchronicle.com
Pulmonx stock plunges to 52-week low of $5.38 amid market challenges By Investing.com - Investing.com South Africa
Charles Schwab Investment Management Inc. Boosts Holdings in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Pulmonx Co. (NASDAQ:LUNG) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Connor Clark & Lunn Investment Management Ltd. Buys 25,988 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World
Insider Sell Alert: French Glendon E. III Sells 20,000 Shares of Pulmonx Corp (LUNG) - GuruFocus
Pulmonx corp director Glendon French sells $157,000 in stock By Investing.com - Investing.com Canada
Pulmonx corp director Glendon French sells $157,000 in stock - Investing.com
Canaccord maintains Buy rating on Pulmonx stock with $16 target By Investing.com - Investing.com Australia
Canaccord maintains Buy rating on Pulmonx stock with $16 target - Investing.com
Boral Capital sets Pulmonx stock Buy rating, $17 target - Investing.com India
Boral Capital sets Pulmonx stock Buy rating, $17 target By Investing.com - Investing.com South Africa
This Pulmonx Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Pulmonx initiated with a Buy at D. Boral Capital - TipRanks
Pulmonx (NASDAQ:LUNG) vs. Spectral Medical (OTCMKTS:EDTXF) Financial Review - The AM Reporter
Reviewing Pulmonx (NASDAQ:LUNG) & Spectral Medical (OTCMKTS:EDTXF) - Defense World
Pulmonx corp’s chief commercial officer sells $41,191 in stock - Investing.com India
Pulmonx corp general counsel sells shares totaling $170,918 - Investing.com India
Pulmonx CFO Mehul Joshi sells $102,414 in stock By Investing.com - Investing.com Australia
Pulmonx Corp CEO Steven Williamson sells $197,699 in stock - Investing.com India
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):